Trial IRCT20200624047908N1
Publication DISCOVER - Mobarak S, J Antimicrob Chemoth (2021) (published paper)
Primary outcome on the report: Hospital discharge within 10 days after randomization where participants were discharged on the managing physician’s decision based on the absence of fever or dyspnoea, no or improved cough and fatigue, and tolerance of oral feeding, with a stable O2 saturation of >=95%.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.